Cancer unmasked by bleeding during anticoagulant therapy: when a problem may become an opportunity

Felicita Andreotti; Aldo Maggioni

doi:10.1093/eurheartj/ehaa164

Related publications

Article2018

Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism

Michela Giustozzi, Maria Cristina Vedovati, Giancarlo Agnelli

Article2021

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism

Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S. Wells, Clive Kearon, Jeffrey I. Weitz, Harry R. Büller, Gary E. Raskob, Walter Ageno, Françis Couturaud, Paolo Prandoni, Gualtiero Palareti, Cristina Legnani, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Geert‐Jan Geersing, Toshihiko Takada, Benilde Cosmi, Drahomir Aujesky, Letizia Marconi, Antonio Palla, Sergio Siragusa, Charlotte Bradbury, Sameer Parpia, Ranjeeta Mallick, Anthonie W.A. Lensing, Martin Gebel, Michael Grosso, Kednapa Thavorn, Brian Hutton, Grégoire Le Gal, Dean Fergusson, Marc Rodger

Article2018

Cancer unmasked by bleeding during anticoagulant therapy: when a problem may become an opportunity

Discussion(0)

Related publications

Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism

Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis

A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide

Point-of-need diagnostics in a post-Covid world: an opportunity for paper-based microfluidics to serve during syndemics